RESUMO
Chloramphenicol single dose eyedrops 0.5% (Nycomed Pharma) have been found to be very sensitive to exposure to light. We could detect approximately 15% decomposition after six hours of exposure to diffuse daylight. One of the decomposition products is the extremely irritant dichloroacetic acid. This may explain why some patients complain of a burning sensation in the eyes. In one of the samples of light yellow eyedrop received together with the complaints our analysis revealed 17% of the end-cleavage product p-nitrobenzaldehyde. The Norwegian Medicines Control Authority will suggest to the producers of these preparations that they market the product in special light-proof containers.
Assuntos
Cloranfenicol/efeitos adversos , Queimaduras Oculares/induzido quimicamente , Soluções Oftálmicas/efeitos adversos , Cloranfenicol/química , Cloranfenicol/efeitos da radiação , Estabilidade de Medicamentos , Humanos , Luz/efeitos adversos , Soluções Oftálmicas/química , Soluções Oftálmicas/efeitos da radiaçãoRESUMO
Substances in the European Pharmacopoeia, reported as having polymorphism are reviewed. For these substances the analyst may expect irregular melting behaviour and IR spectra.